KLK3 and prostate cancer: Similarly, a study conducted at the Soba and Omdurman teaching hospitals from 2011–2012 found that both the serum levels of early prostate cancer antigen-2 and PSA were significantly raised (compared to healthy controls) and could be used as useful prognostic and screening markers for prostate cancer.